Health
Gracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for Treatment of Relapsed/Refractory Multiple Myeloma
Approval follows U.S. FDA clearance of IND application for BCMA/CD19 dual-targeting FasTCAR-T GC012F Company plans to initiate Phase 1/2 clinical trial in China in third quarter of 2023 SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China, Feb. 13, 2023 /PRNewswire/ -- Gracell Biotechnologies Inc. ...
2023-02-13 20:30
1972
Vmade Launched Cooperation with Fulgent Life to Build a Cross-Border SaaS and Payment Integration Solution for Private Growth
BEIJING, Feb. 13, 2023 /PRNewswire/ -- WeTrade Group Inc. ("WeTrade" or the
"Company") (NASDAQ: WETG
2023-02-13 20:00
2184
Completion Of The First Batch Of Subject Enrollment For The Phase I Clinical Trial Of The Company's Novel Adjuvanted Recombinant Shingles Vaccine REC610
TAIZHOU, China, Feb. 13, 2023 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that the Group has recently completed the first batch of subject enrollment for its novel adjuvanted recombinant shingles vaccine, ...
2023-02-13 15:02
3478
Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) Arterial Disease
TAMPA, Fla., Feb. 13, 2023 /PRNewswire/ -- Concept Medical Inc.
2023-02-13 14:53
2057
B dot Medical to Install Ultra-compact Proton Therapy System at Thammasat University in Thailand
- Responding to Growing Needs for Urban-type Proton Therapy in Thailand - TOKYO and BANGKOK, Feb. 13, 2023 /PRNewswire/ -- B dot Medical Inc. and Thammasat University, a leading national university in Thailand, have signed a memorandum of understanding to install the ultra-compact proton therapy ...
2023-02-13 14:00
2070
Boan Biotech's Investigational Anti-CD25 Antibody BA1106 Administered for First Patient in Phase I Clinical Trial
YANTAI, China, Feb. 13, 2023 /PRNewswire/ -- Luye Pharma Group today announced that BA1106, an investigational non-IL-2 blocking anti-CD25 antibody developed by its subsidiary Boan Biotech, has been administered for the first patient in a Phase I clinical trial. This trial is designed to evaluate...
2023-02-13 08:39
2748
VISTA Eye Specialist to Showcase Latest Eye Care Technology
PETALING JAYA, Malaysia, Feb. 13, 2023 /PRNewswire/ -- In collaboration with Ziemer Ophthalmic Systems AG (Ziemer), one of the leading Ophthalmic companies based inSwitzerland, VISTA Eye Specialist (VISTA) will be hosting surgeons from around the world on 22nd February, to participate in a variet...
2023-02-13 08:00
4592
TS7000dV Surgical Table: First Integrated Table Motion for the da Vinci Xi Surgical System appears at Device Technologies Asia Training Center
Hands-on experience of the seamlessly integrated ITM for a more efficient workflow with dynamic access during procedures for RAS surgeons and field experts. SINGAPORE, Feb. 11, 2023 /PRNewswire/ -- Developed jointly by Baxter and Intuitive, the TS7000dV Surgical Table, an integrated table motion ...
2023-02-11 08:42
5071
CGTN: Reflecting on China's Three-year COVID Battle in Through the Storm
BEIJING, Feb. 10, 2023 /PRNewswire/ -- Since early 2020, China has been following a unique path in combatting COVID-19.Through the Storm condenses this three-year battle into a 60-minute documentary.   This CGTN presentation has its global premiere on February 10. Through the S...
2023-02-10 22:02
4913
Kintor Pharma Announces Positive Top-line U.S. Phase I Trial Results of GT20029, the World's First Topical Use PROTAC Compound
SUZHOU, China, Feb. 10, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced the positive top-line results from the U.S. Phase I clinical trial of GT200...
2023-02-10 21:19
3784
HanAll Biopharma Invests in Interon to Seek Collaboration Opportunities
* HanAll will invest in Interon Laboratories, a preclinical-stage biotechnology company focused on treating complex neurological disorders * Interon is developing a new category of immunotherapy for people with neurological and immune disorders starting with autism spectrum disorder SEOUL, So...
2023-02-10 20:00
2846
Tianlong New Product Panall 8000 Shines at Medlab Middle East 2023
XI'AN, China, Feb. 10, 2023 /PRNewswire/ -- Medlab Middle East 2023, a leading exhibition of laboratory medicine in ME region, was unveiled at Dubai World Trade Center from 6 to 9 February. As Tianlong's first show of 2023, we are well prepared and thrilled to welcome guests from all over the w...
2023-02-10 17:42
2929
Leveraging Digital Technologies Can Help Grow Strong and Sustainable Communities
Capacity-building efforts provide the poor with sustainable tools that they can use to improve their circumstances and remove themselves from the poverty cycle SAN ANTONIO, Feb. 10, 2023 /PRNewswire/ -- In 2020, global poverty increased for the first time since the Asian financial crisis of the l...
2023-02-10 16:12
2170
Nippon Express Obtains GDP Certification of Compliance with WHO Standards at 2 Domestic Locations: West Japan Pharmaceutical Center and Kyushu Pharmaceutical Center
- Storage and Transport Offered in Two Temperature Ranges, Following East Japan Pharmaceutical Center - TOKYO, Feb. 10, 2023 /PRNewswire/ -- Nippon Express Co., Ltd. (hereinafter "Nippon Express"), a group company of NIPPON EXPRESS HOLDINGS, INC., has acquired Good Distribution Practice (GDP) ce...
2023-02-10 14:00
2620
Nona Biosciences Enters into HCAb Based Antibody Discovery Collaboration Agreement with Mythic Therapeutics
CAMBRIDGE, Mass., Feb. 10, 2023 /PRNewswire/ -- Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited committed to cutting edge technology innovations, and providing a total solution from "Idea to IND" ("I to ITM"), today announced that it has entered into a collaboration agreement ...
2023-02-10 13:00
1880
AcuraBio expands cGMP plasmid DNA CDMO services with Cytiva's latest single-use purification technology to alleviate supply constraints for mRNA and cell & gene therapies
* AcuraBio selects Cytiva's latest two-step purification protocol to offer a productive plasmid DNA service to its customers globally to alleviate supply constraints for mRNA and cell & gene therapies * The latest purification technology will offer efficient processing time for plasmid DNA pr...
2023-02-10 09:34
6088
Everest Medicines Announces South Korea Grants Fast Track Review Designation to Nefecon for the Treatment of Primary IgA Nephropathy
SHANGHAI, Feb. 10, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing, manufacturing and commercializing transformative pharmaceutical products and vaccines inGreater China and other parts of Asia, announced today that South Korea's Ministry o...
2023-02-10 07:30
4606
REWE International will rely on Körber's Warehouse Management System
One of Austria's leading food and drugstore retailers drives supply chain optimization at roundabout 40 locations inAustria and Eastern Europe HAMBURG, Germany, Feb. 10, 2023 /PRNewswire/ -- REWE International AG has chosenKörber's Warehouse Management System (WMS) to be deployed across roundabo...
2023-02-10 06:00
2410
AcuraBio expands cGMP plasmid DNA CDMO services with Cytiva's latest single-use purification technology to alleviate supply constraints for mRNA and cell & gene therapies
* AcuraBio selects Cytiva's latest two-step purification protocol to offer a productive plasmid DNA service to its customers globally to alleviate supply constraints for mRNA and cell & gene therapies * The latest purification technology will offer efficient processing time for plasmid DNA pr...
2023-02-10 04:34
2627
Syntach AB announces partnership with Meditrial CRO to drive clinical development of groundbreaking Cardiac Support System
LUND, Sweden, Feb. 10, 2023 /PRNewswire/ - Syntach AB ("Syntach") is pleased to announce that it has entered into a partnership agreement with Meditrial Europe Ltd ("Meditrial") to support the clinical and regulatory strategies of Syntach's innovative minimally invasive cardiac support system. ...
2023-02-10 03:00
2595
Week's Top Stories
Most Reposted
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
[Picked up by 350 media titles]
2024-06-19 11:00
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
[Picked up by 335 media titles]
2024-06-20 16:24
k-ID Closes $45 Million Series A from Andreessen Horowitz and Lightspeed Venture Partners to Set a New Global Benchmark for Age-appropriate Gaming Experiences
[Picked up by 318 media titles]
2024-06-25 21:00
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
[Picked up by 317 media titles]
2024-06-19 08:05THEIR ROYAL HIGHNESSES THE DUKE AND DUCHESS OF EDINBURGH CELEBRATE THE GRAND OPENING OF THE PENINSULA LONDON, BELGRAVIA
[Picked up by 313 media titles]
2024-06-19 11:38
Most Read
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
2024-06-19 11:00
15695
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
2024-06-20 16:24
13476
THEIR ROYAL HIGHNESSES THE DUKE AND DUCHESS OF EDINBURGH CELEBRATE THE GRAND OPENING OF THE PENINSULA LONDON, BELGRAVIA
2024-06-19 11:38
9533
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
2024-06-19 08:05
9442
